文献速递肺结节与肺癌

代谢综合征与肺癌风险:基于人群的前瞻性队列研究

Association of Metabolic Syndrome With Risk of Lung Cancer: A Population-Based Prospective Cohort Study.
PubMed 文献 · Chest · 2023-08-10

该研究基于英国生物银行331,877名参与者,采用多变量Cox回归分析代谢综合征(MetS)及其组分与肺癌风险的关系。中位随访10.9年期间2,425人发生肺癌,MetS与肺癌总体风险(HR 1.21,95%CI 1.09-1.33)和腺癌风险(HR 1.28,95%CI 1.10-1.50)升高相关,且风险随代谢异常数目增加而上升。

要点

  • MetS与肺癌总体风险及腺癌风险升高相关,鳞癌关联未达统计学显著。
  • 低HDL-C、腰围增大和高血糖与肺癌风险呈正相关。

核心结论

  • MetS与肺癌风险升高相关,提示在肺癌一级预防和高危人群筛选中应考虑代谢状态及指标。

研究设计与样本

  • 基于英国生物银行的前瞻性队列研究,纳入331,877名参与者,其中77,173名在入组时诊断为MetS。
  • 采用多变量Cox回归模型估计MetS相关变量与肺癌风险的风险比(HR),并按组织学亚型分析。
  • 按性别、吸烟状态和用药情况进行分层分析,并使用HR曲线检验非线性关联。

主要发现

  • 中位随访10.9年期间,2,425名参与者发生以肺原发部位的肺癌。
  • MetS与肺癌总体风险的HR为1.21(95%CI 1.09-1.33),与腺癌的HR为1.28(95%CI 1.10-1.50),与鳞状细胞癌的HR为1.16(95%CI 0.94-1.44)。
  • 随着代谢异常数目从1种增至5种,HR从1.11上升至约1.4或1.5。
  • 低HDL-C、腰围增大和高血糖与肺癌风险呈正相关。

临床怎么用

  • 在肺癌一级预防和高危人群筛查选择中,应考虑代谢状态和代谢标志物。
  • 对于合并MetS(尤其低HDL-C、中心性肥胖、高血糖)的人群,可加强肺癌风险关注。
  • 女性MetS患者的肺癌风险关联更强,临床评估时需注意性别差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Both the incidence of lung cancer and the prevalence of metabolic syndrome (MetS) have been increasing worldwide. The relationship between MetS and lung cancer remains controversial. RESEARCH QUESTION: What is the risk of lung cancer associated with MetS and its components? STUDY DESIGN AND METHODS: Multivariable Cox regression models were used to estimate the hazard ratio (HR) of MetS-related variables on lung cancer risk, both overall and by histologic subtype, in the UK Biobank. Stratified analyses were conducted by sex, tobacco use status, and use of medication. HR curves were used to test the nonlinear associations between the metabolic markers and the risk of lung cancer. RESULTS: Of the 331,877 participants included in this study, a total of 77,173 participants had a diagnosis of MetS at enrollment. During a median follow-up of 10.9 years, lung cancer as the primary site developed in 2,425 participants. The HRs of MetS were 1.21 (95% CI, 1.09-1.33), 1.28 (95% CI, 1.10-1.50), and 1.16 (95% CI, 0.94-1.44) for the overall risk of lung cancer, adenocarcinoma, and squamous cell carcinoma, respectively. The HRs increased with the number of metabolic abnormalities from 1.11 to approximately 1.4 or 1.5 for those with one to five disorders. Positive association with lung cancer was observed for low high-density lipoprotein cholesterol (HDL-C), elevated waist circumference, and hyperglycemia. The relationship between MetS and lung cancer was modified by sex, with a stronger effect in female patients (P = .031). The risk of lung cancer resulting from MetS was elevated mainly among individuals who used tobacco, although the modification effect of tobacco use was not statistically significant. A nonlinear association was found between lung cancer and HDL-C, waist circumference, and glycated hemoglobin. INTERPRETATION: The increased risk of lung cancer associated with MetS suggests the importance of taking metabolic status and markers into consideration for the primary prevention of lung cancer and the selection of high-risk populations for lung cancer screening.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Li M, Cao SM, Dimou N, et al. Association of Metabolic Syndrome With Risk of Lung Cancer: A Population-Based Prospective Cohort Study. Chest. 2023. PMID: 37572975. doi:10.1016/j.chest.2023.08.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。